NewsBenzingaKymera Therapeutics、第3四半期EPSは(1.32ドル)で予想の(1.27ドル)を下回る Kymera Therapeutics、第3四半期EPSは(1.32ドル)で予想の(1.27ドル)を下回る Benzinga 2026.10.29 11:05 (GMT+0) Open on Benzinga Other news Freedom Broker Maintains Buy on XPeng, Lowers Price Target to $20 Plug Power Shares Slide Toward 52-Week Low Despite New 280-MW Texas Deal Nvidia Vs. Anthropic: Can the AI IPO Challenge Nvidia’s Dominance Across ETFs? Freedom Broker Maintains Buy on Allot, Lowers Price Target to $12.7 Freedom Broker Upgrades M-Tron Industries to Buy, Lowers Price Target to $84 As decision model use skyrockets, is customization is the next frontier?